To ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The Second Chance at Life Act of 2025 requires abortion providers to inform women at least 24 hours before a mifepristone-induced chemical abortion that it may be possible to reverse the effects if they change their mind. Providers must give written discharge instructions about reversal after dispensing the first pill. Clinics must post conspicuous signs about abortion pill reversal, and the Department of Health and Human Services must create and maintain a website with reversal information in multiple languages.
Who Benefits and How
Abortion pill reversal (APR) service providers and the organizations that promote them gain official government endorsement and a federally maintained referral website. Anti-abortion advocacy organizations benefit from codifying their messaging into federal law. Women who change their mind about a chemical abortion gain access to information about potential reversal options.
Who Bears the Burden and How
Abortion providers face new informed consent requirements, mandatory 24-hour waiting periods for chemical abortions, and signage mandates. Non-compliant providers face civil lawsuits for actual and punitive damages from patients, fathers, or parents. The Department of Health and Human Services must develop and maintain a website within 30 days of enactment. States cannot use this law to weaken their existing abortion disclosure requirements.
Key Provisions
- Mandatory informed consent about abortion pill reversal at least 24 hours before a mifepristone-induced chemical abortion
- Required signage in all facilities performing chemical abortions about the possibility of reversal
- Civil cause of action allowing patients, fathers, and parents to sue non-compliant providers for actual and punitive damages
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires abortion providers to inform patients about the possibility of reversing mifepristone-induced chemical abortions before performing the procedure, mandates signage in facilities, creates an HHS website with reversal information, and establishes civil liability for non-compliance.
Key Policy Areas
Healthcare, Reproductive Health, Consumer Protection
Primary Purpose
Requires abortion providers to inform patients about the possibility of reversing mifepristone-induced chemical abortions before performing the procedure, mandates signage in facilities, creates an HHS website with reversal information, and establishes civil liability for non-compliance.
Policy Domains
Abortion Pill Reversal Informed Consent (Title XXXIV of PHSA)
Identified Gains
Contextual inference, no direct clause citation- Abortion pill reversal service providers
- Anti-abortion advocacy organizations
- Women who reconsider chemical abortion
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Abortion providers and clinics
- Department of Health and Human Services
- Reproductive health organizations
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMr. Pfluger (for himself, Mr. LaMalfa, Mr. Estes, Mr. Moore …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Abortion pill reversal advocates and providers, Abortion pill reversal service providers, Abortion providers and clinics performing chemical abortions
Positive-direction: Abortion pill reversal advocates and providers, Abortion pill reversal service providers, Abortion providers in emergency situations
Negative-direction: Abortion providers and clinics performing chemical abortions, Abortion providers in states with extensive disclosure laws, Abortion providers performing chemical abortions, Abortion providers who violate informed consent requirements, Clinics and facilities performing chemical abortions, Hospitals with abortion services, Telehealth abortion providers
Women seeking chemical abortions, Women, fathers, and parents of minors
Medical malpractice insurers covering abortion providers
States with stricter abortion disclosure laws
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
A female human being whether or not she has reached the age of majority.
A member of the species homo sapiens, at any stage of development prior to birth.
Any person licensed to perform a chemical abortion under applicable Federal and State laws.
The use or prescription of an abortion-inducing drug dispensed with the intent to cause the death of the unborn child.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology